A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis

A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201

NCT00831649 ·Status: TERMINATED ·Phase: PHASE2

An Open Label Extension Study in Participants With Rheumatoid Arthritis

NCT00837811 ·Status: COMPLETED ·Phase: PHASE2

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

NCT01636817 ·Status: TERMINATED ·Phase: PHASE2

Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

NCT00963703 ·Status: COMPLETED ·Phase: NA

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)

NCT01362153 ·Status: COMPLETED ·Phase: PHASE1

A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis

NCT06887127 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

NCT01463059 ·Status: COMPLETED ·Phase: PHASE2

A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

NCT00718718 ·Status: COMPLETED ·Phase: PHASE2

A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT02097264 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT06738719 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis

NCT02919761 ·Status: COMPLETED ·Phase: PHASE4

A Study With CIT-013 in RA Patients

NCT06567470 ·Status: RECRUITING ·Phase: PHASE2

First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis

NCT00927927 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Efficacy and Safety of CT-P10 in Patients With RA

NCT01873443 ·Status: COMPLETED ·Phase: PHASE1

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

NCT00837434 ·Status: COMPLETED ·Phase: PHASE4

Study of an Anti-TLR4 mAb in Rheumatoid Arthritis

NCT03241108 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY2439821 in Rheumatoid Arthritis

NCT01236118 ·Status: COMPLETED ·Phase: PHASE1

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

NCT01021735 ·Status: COMPLETED ·Phase: PHASE4

Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

NCT01481493 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

NCT07258849 ·Status: RECRUITING ·Phase: PHASE1

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis

NCT01878123 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

NCT01638715 ·Status: COMPLETED ·Phase: PHASE4

Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis

NCT02528292 ·Status: UNKNOWN

A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis

NCT01026519 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

NCT01557348 ·Status: COMPLETED